CPIX
CUMBERLAND PHARMACEUTICALS INC
Key Financials
Revenue
$44.5M
↑ 225.5%
Net Income
$-2836128
↓ 100.9%
Operating Income
$-2791993
↓ 103.6%
Total Liabilities
$52.3M
↓ 1.4%
Cash & Equivalents
$11.4M
↓ 36.3%
Total Assets
$76.8M
↑ 1.6%
EPS (Diluted)
$-0.19
↓ 111.1%
Shareholders' Equity
$24.9M
↑ 8.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 7/1/2026 | View on SEC |
| 8-K | 6/25/2026 | View on SEC |
| DEFM14A | 5/26/2026 | View on SEC |
| PREM14A | 5/15/2026 | View on SEC |
| 10-Q | 5/8/2026 | View on SEC |
| 8-K | 5/5/2026 | View on SEC |
| 8-K | 4/24/2026 | View on SEC |
| DEFA14A | 4/23/2026 | View on SEC |
| 8-K | 4/23/2026 | View on SEC |
| 4 | 3/20/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CPIX |
| Company Name | CUMBERLAND PHARMACEUTICALS INC |
| CIK | 1087294 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | TN |
| Phone | 615-255-0068 |